Generalized recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited autosomal disease characterized by dermolytic blister formation. Enhanced collagenase and/or abnormal collagenase have been reported in skin from affected patients, suggesting that collagenase could be responsible for the absence of anchoring fibrils in this disorder. We used a genetic linkage approach to test the hypothesis that this disease is due to a defect in the collagenase gene in nine affected families. Analysis of amplified genomic DNA fragments of the collagenase gene by means of denaturing gradient gel electrophoresis (DGGE) allowed us to detect intragenic polymorphisms, which were subsequently characterized by direct genomic sequencing. Segregation analysis of these polymorphic sites showed exclusion of linkage between the collagenase gene and generalized RDEB phenotype in a family with consanguineous parents and three affected children. However, the possibility of linkage with the collagenase gene in the other eight families tested could not be excluded. The genetic markers described here provide a tool for investigating genetic linkage in other affected families. Overall, our results show that generalized RDEB can be caused by a defect in a gene other than the collagenase gene, and support the hypothesis that the genetic defect lies in abnormal anchoring fibril formation. (J. Clin. Invest. 1991. 88:1716-1721
Introduction
Epidermolysis bullosa (EB)' is a group of rare genetic diseases responsible for skin blistering in response to mild trauma. The generalized, dystrophic type of EB (i.e., Hallopeau-Siemens variant, MIM No. 226600) is a severe autosomal recessive con-1. Abbreviations used in thispaper: AF, anchoring fibrils; DGGE, denaturing gradient gel electrophoresis; EB, Epidermolysis bullosa; PCR, polymerase chain reaction; RDEB, recessive dystrophic epidermolysis bullosa.
dition, characterized by early, extensive skin blistering, with dystrophic healing of the hands and feet, and nail and mucous membrane involvement (1, 2) . In this kind of EB, the blister occurs between the epidermis and papillary dermis, just beneath the lamina densa. Ultrastructural analyses have shown collagen degeneration, with phagocytosis of collagen fibrils by macrophages in the upper dermis, associated with the absence or rudimentary appearance of anchoring fibrils (3, 4) . These morphologic findings suggested that recessive dystrophic epidermolysis bullosa (RDEB) might be caused either by excessive collagenase activity resulting in connective tissue destruction and decreased or absent anchoring fibrils, or by a primary defect in anchoring fibril formation (5) .
A number of in vivo and in vitro biochemical studies supported the hypothesis that enhanced collagenase activity was of pathologic importance in RDEB. Increased collagenase activity was first reported in explant cultures of blistered skin from RDEB patients (6, 7) ; subsequent in vivo investigations found high tissue levels of collagenase in both blistered and clinically uninvolved skin from patients with RDEB (8) . In addition, cultures of fibroblasts from patients with RDEB demonstrated an increased capacity to synthesize and secrete collagenase (9-1 1). Because the other inherited forms of EB did not display these abnormalities, it was suggested that collagenase overexpression was a specific biochemical feature of RDEB (12) , and that the determination of collagenase activity and concentrations in fetal skin fibroblast culture supernatant could be helpful in prenatal diagnosis (13) . Furthermore, phenytoin, an agent that inhibits collagenase synthesis, has been used in the treatment of RDEB patients with inconclusive results (14, 15) .
The possibility that a structural gene mutation might give rise to a mutant form of collagenase was raised by Bauer (16) (17) (18) who found that cultured skin fibroblasts from four RDEB patients produced structurally abnormal collagenase with altered biochemical properties. Moreover, the recent demonstration that collagenase is able to degrade type VII collagen (19) , the major component of anchoring fibrils (AF) (20) , suggested that excessive collagenase activity could account for the absence of AF in this disease.
On the other hand, recent immunofluorescence and immunoelectron microscopy studies have demonstrated abnormal in vivo and in vitro expression of type VII collagen in the skin of RDEB patients (21) (22) (23) (24) (25) (26) (27) . However, whether blister formation in these subjects is related to a primary defect in the gene coding for type VII collagen, or to an excessive degradation of AF by collagenase remains to be determined (28) (29) (30) (31) .
As a first step in investigating the genetic basis of this disease, we used a genetic linkage approach to test the hypothesis that it results from a defect in the collagenase gene. In this study, we characterized intragenic polymorphisms, and ana- 
Patients
We studied nine unrelated families with generalized RDEB ( 
Analysis ofthe PCR products
Gel electrophoresis. The amplified products were analyzed by means of electrophoresis on 6% polyacrylamide gels and denaturing gradient gels according to a previously described method (34) which permits the detection of single basepair variations within a double-stranded DNA fragment run on a gel containing an increasing denaturant concentration (35) . The melting ofthe lowest temperature melting domain ofthe fragment retards its mobility, thus permitting the separation of DNA fragments whose nucleotide sequences differ within their first melting domain. The electrophoretic pattern observed after denaturing gradient gel electrophoresis (DGGE) is formed ofbands that correspond to homoduplexes (resulting in reassociation ofcomplementary strands of one allele), and heteroduplexes formed between two different alleles. One-fifth of each PCR product was electrophoresed on a vertical 6.5% Numbers refer to the nucleotide position within intronic (I) and exonic (E) regions.
Direct sequencing of amplified DNA. Single-strand DNA suitable for sequencing was generated in the polymerase chain reaction using unequal amounts ofprimers p1 and p2 (50 pmol/ I pmol) as previously described (36) . The product of asymmetric amplification was concentrated using a Centricon 100 (Amicon Corp., Danvers, MA) and an aliquot of this material was used as DNA template for sequencing by means of the dideoxynucleotide termination method (37) using a Sequenase kit (United States Biochemical Corp., Cleveland, OH) and a-35S dATP (400 Ci/mmol) (Amersham Corp., Arlington Heights, IL). The oligonucleotides used for sequencing (primers pl-p9) ( Fig. 1 B) were synthesized on a 380B DNA synthesizer (Applied Biosystems, Inc., Foster City, CA).
Computer analysis
Computational simulation ofDNA melting ofthe plp2-amplified gene segment was performed using Lerman's Melt 87 program which predicts the melting properties ofa DNA fragment according to its nucleotide sequence (38). The sets of primers used to test the different fusion domains were selected according to their position and orientation on the melting map (Fig. 1) . The denaturing conditions resulting in optimal resolution and heteroduplex formation were determined by displacement calculation using Lerman's SQHTX program (38).
Linkage analysis
Linkage analysis was performed using the LINKAGE program (39) . Lod score2 calculations were performed by designating RDEB as a recessive disease with complete penetrance, taking into account the consanguinity in families I and V. Heterogeneity analysis was performed with the Homog program (40) .
Results
Because no collagenase gene restriction fragment length polymorphism has been described, we looked for nucleotide polymorphisms useful in linkage studies by means of DGGE. We selected two primers that allowed the amplification ofa 1,605-bp region spanning exons 4-6, thus including exon 5, which encodes the catalytic site ofthe enzyme (41) , and its two flanking introns.
Detection ofpolymorphic sites within the collagenase gene An amplified product ofexpected size was obtained upon PCR amplification of the 1,605-bp DNA fragment in all subjects 2. A lod-score is defined as the log 10 of the odds that the disease and marker loci are linked rather than unlinked at a specific recombination fraction. from family I, ruling out a deletion within this fragment (data not shown). When these amplified products were tested for DNA melting polymorphisms by means of DGGE, different patterns were observed among the members ofthis family, suggesting the existence of several nucleotide sequence polymorphisms. To correlate the melting patterns observed with the nucleotide sequence of the fragment, we determined the complete sequence ofthis DNA fragment in one member of family I by direct genomic sequencing. The melting behavior of the fragment (Fig. 1 A) was predicted using Lerman's computer program. The fusion map contains five low melting domains (A-E) which were analyzed using different sets of primers (p1-p8, pl-p6, pl-p4, and p5-p6) (Fig. 1 B) to identify the domain that contains the polymorphism. As the PCR products generated with primers p5-p6 (550-bp fragment) (Figs. 1 B and 2 B) and pl-p2 (full-length 1,605-bp fragment) displayed similar DGGE patterns, we restricted our analysis to this limited segment ofthe collagenase gene in all the RDEB patients and their families. The pattern obtained with primers p5-p6 in family I is shown in Fig. 2 C. Direct genomic sequencing of this 550-bp amplified product allowed us to characterize four polymorphic sites within the fourth intron. Two ofthem, located in the early melting region ofthe fragment (domain C) (Fig. 1) , were likely to be responsible for the DGGE pattern observed. These C-to-A and T-to-G substitutions (at positions 739 and 837, respectively) (Fig. 3) did not affect any known restriction enzyme recognition sites. The two other polymorphic sites (C-to-T substitution at position 433, and A-to-T substitution at position 545) could not be detected by DGGE because they were located in a highly stable region of the fourth intron (Fig. 1) .
Collagenase gene haplotypes and their use in linkage analysis These four polymorphic sites defined seven haplotypes that are summarized in Table III ; their distribution in the RDEB families is shown in Fig. 4 . The parental phases of the collagenase alleles were established by segregation analysis within each family. The linkage between the disease and the collagenase alleles in each family was tested by lod score analysis, and the results are given for a recombination fraction (0) of 0.00 (Table I) .
Family I: exclusion of linkage. Family I (consanguineous parents and three affected siblings) was found to be informative for the polymorphic sites tested (i.e., the parents were heterozygous at the collagenase locus, with one differing haplotype) (Fig. 2 C) genetic linkage between the collagenase gene and the RDEB phenotype. First, the three affected siblings were heterozygous at the collagenase locus. This is not consistent with the notion that in rare recessive inherited diseases, affected children from consanguineous families are expected to be homozygous for the defective allele inherited from a common ancestor (42) . Second, ifthere were linkage between the collagenase gene and RDEB, all the affected children within a given family should have the same genotype at the collagenase locus. However, the pedigree of family I shows that the three affected siblings had different collagenase genotypes (3-cd; 4-bd; 5-bc) (Fig. 2 D) . Furthermore, the first affected sibling (3-cd) had the same collagenase genotype as his phenotypically normal brother (6-cd lies ranged from -0.35 to 0.73 atO = 0.00 (Table I) . Overall, the maximum lod score when family I was included was 0.78 at 0 = 0.10 (P < 0.05). The test of heterogeneity (i.e., a test of linkage within a subset of families) was not significant (P = 0.25).
Discussion
In this study, we tested the hypothesis that generalized RDEB is due to a defect in the collagenase gene. Nine families with at least one child suffering from generalized RDEB were studied. We focused on the molecular analysis of a 1,605-bp fragment of the collagenase gene which contained two interesting se- Table III. quences, i.e., the sequence (exon 5) coding for the catalytic domain, thus a possible target for deleterious mutations, and its adjacent intronic regions (introns 4 and 6) which could display nucleotide polymorphisms. DGGE analysis ofthis amplified gene fragment in one family with consanguineous parents and three affected children revealed multiallele polymorphisms that we subsequently characterized by direct genomic sequencing. These polymorphisms did not cosegregate with the RDEB phenotype, excluding linkage ofthis gene to the disease in family I. Though statistically very unlikely, the possibility of a dominant form of the disease in this kindred, resulting from a germ line mutation in three different gametes, could have been considered. However, this possibility was formally excluded given the severe mittenlike deformities of the hands and feet observed in the oldest and most severely affected offspring: this clinical feature has not been described in any dominant form of dystrophic epidermolysis bullosa (EB), but is characteristic of the generalized recessive form of dystrophic EB (Hallopeau-Siemens variant).
Using the same genetic approach, we performed linkage analysis between the RDEB phenotype and the collagenase haplotypes in eight other affected families. The role of a defect in the collagenase gene in the disease could not be ruled out in these families in which no obligate recombination events were found. Indeed, the maximum lod score was 0.78 at 0 = 0.10 for all the families (including family I). It should be recalled that the usual requirement for significant linkage (a lod score > 3) applies to linkage between a random marker and the disease locus, and that a less stringent criterion can be applied to the examination of a candidate gene, in this case, collagenase. The result ofthe formal test for heterogeneity, in which the hypothesis of linkage within a subgroup of families is examined, was not statistically significant. These results suggest that the study of linkage between the collagenase gene and the RDEB phenotype in further affected families would be warranted.
Several authors have implicated increased (6-12, 29-31) and/or abnormal collagenase (12, (16) (17) (18) in the pathogenesis of blister formation in RDEB. In particular, collagenase overexpression has been found in clinically uninvolved skin (8) and in cultured fibroblasts from patients with RDEB (9). This biochemical trait was considered to be specific for this form ofEB, and was shown to persist through several cell passages, suggesting that it was genetically determined (9) . In addition, the recent demonstration that collagenase is able to degrade type VII collagen (19) , the major component of anchoring fibrils (20) , reinforced the candidate gene status of collagenase.
Other authors reported the isolation of a structural variant ofcollagenase produced by cultured fibroblasts from four unrelated patients with generalized RDEB (16) (17) (18) . This abnormal form of the enzyme was expressed at high levels and exhibited increased thermolability, decreased calcium affinity, and a slightly different global amino acid composition, but normal catalytic activity towards types I and III collagen (12, (16) (17) (18) . The catalytic activity of the mutant form towards type VII collagen has not been studied, and its cDNA sequence has not been published. Overall, these data suggested that RDEB might be caused by a defect in the regulation of the collagenase gene, or in the structure of the gene itself.
The candidate gene approach we used excluded any linkage between the collagenase gene and generalized RDEB in one of the affected families studied. Indeed, our strategy, which is based on linkage analysis, allowed us to test the involvement of the genetic region encompassing the collagenase gene in the RDEB phenotype. Though we focused our analysis on a region of the gene spanning the active site of the collagenase, our results are not contingent upon the location of a putative defect within the collagenase gene.
So far, we cannot exclude linkage between the collagenase gene and the disease in all other affected families because RDEB is likely to be a heterogeneous disorder (2, 43, 44) . Indeed, Bauer reported that collagenase production by cultured skin fibroblasts was only enhanced in eight of 10 patients with RDEB (9) , and in a recent study of Scandinavian RDEB patients, collagenase overexpression was only found in cultured fibroblasts from four of 18 RDEB patients (44) . Similarly, we found that cultured fibroblasts from only two of the three affected siblings in family I expressed high levels of collagenase mRNA (data not shown), suggesting that collagenase mRNA overexpression was not the primary defect in this family.
Furthermore, our results demonstrate that in RDEB family I, the absence of anchoring fibrils was not due to a primary defect in the collagenase gene. An 
